During the past decade, The Second Affiliated Hospital Of China Medical University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital Of China Medical University" are "Multiple Myeloma" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "The Second Affiliated Hospital Of China Medical University" in a lesser frequency.

Most popular intervention types in "The Second Affiliated Hospital Of China Medical University" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Revlimid (lenalidomide)" (1 trials), "Vildagliptin 50 mg bid" (1 trials) and "Vildagliptin 50 mg qd" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Second Affiliated Hospital Of China Medical University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The Second Affiliated Hospital Of China Medical University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Second Affiliated Hospital Of China Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Second Affiliated Hospital Of China Medical University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".